Plasma cells are the terminally differentiated product of B cells: surface CD19 falls, CD138 (syndecan-1) and CD38 rise, and the cell becomes an antibody factory. They matter in autoimmune disease, multiple myeloma and vaccine-response studies.
Plasma cells are the terminally differentiated product of B cells: surface CD19 falls, CD138 (syndecan-1) and CD38 rise, and the cell becomes an antibody factory. They matter in autoimmune disease, multiple myeloma and vaccine-response studies.
Protocol 3 of 3 in B cells. The Chinese edition of this page carries the full bench-level detail, including reagent volumes and step timings: Chinese edition.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.